| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Boston Scientific Corporation (BSX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. BSX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.59M | $78.39M | +186.2K | |
| VP | 168.0K | $8.28M | - | |
| Dir | 24.1K | $1.19M | - | |
| Dir | 15.1K | $742.5K | +1.2K | |
| VP | 14.8K | $729.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Brennan Daniel J.47 | EVP And CFO | Sale+OE | 84,863 | $105.10 | $8,919,295.52 | -10.7% | +0.8% | -28.3% | |
| Feb 14, 2025 | Sorenson John Bradley55 | EVP, Global Operations | Sale+OE | 1,201 | $106.31 | $127,678.31 | -4.5% | -1.2% | -29.6% | |
| Feb 12, 2025 | Brennan Daniel J.47 | EVP And CFO | Sale+OE | 15,087 | $105.07 | $1,585,135.27 | -5.9% | -2.7% | -29.9% | |
| Feb 12, 2025 | Sorenson John Bradley55 | EVP, Global Operations | Sell | 6,389 | $105.06 | $671,249.42 | -20.8% | -2.7% | -29.9% | |
| Feb 12, 2025 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 13,022 | $105.06 | $1,368,073.09 | -31.4% | -2.7% | -29.9% | |
| Feb 11, 2025 | Ludwig Edward J62 | Director | Sell | 12,000 | $105.48 | $1,265,815.20 | -33.0% | -2.9% | -30.7% | |
| Feb 7, 2025 | Sorenson John Bradley55 | EVP, Global Operations | Sell | 6,528 | $104.97 | $685,244.16 | -19.8% | -1.9% | -27.5% | |
| Feb 3, 2025 | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sale+OE | 17,313 | $101.80 | $1,762,507.23 | -46.6% | +1.1% | -11.1% | |
| Jan 3, 2025 | Brennan Daniel J.47 | EVP And CFO | Sale+OE | 9,689 | $89.86 | $870,636.10 | -4.1% | +8.6% | +4.4% | |
| Jan 3, 2025 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sale+OE | 7,152 | $89.86 | $642,657.98 | -20.1% | +8.6% | +4.4% |